Acumen Pharmaceuticals, Inc.

This Current Report on Form 8-K contains forward-looking statements. Any statement describing the Company’s goals, expectations, financial or other projections, intentions or beliefs is a forward-looking statement and should be considered an at-risk statement. Words such as “expects,” “anticipates,” “could,” “should,” “would,” “intends,” “estimates,” “may,” “potential,” “will,” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Forward-looking statements include statements concerning the Company’s estimate of expenses that it will incur in connection with the Restructuring, the expected timing for completion of the Restructuring and the timing of the associated charges, as well as statements with respect to additional costs the Company may incur in connection with its evaluation of strategic options, including the retention of outplacement and advisory services and related matters. These statements are based upon the current beliefs and expectations of the Company’s management, and are subject to certain factors, risks and uncertainties, including the risk that the Company’s implementation of the Restructuring, including, without limitation, the reduction in force, as well as its evaluation of potential strategic options, may be unsuccessful, cause disruptions or create unintended consequences. Risks concerning the Company’s programs are described in additional detail in the Company’s filings with the SEC, including in the Company’s most recent Quarterly Report on Form 10-Q and Annual Report on Form 10-K and in subsequent filings with the SEC. Additional information will be made available in other filings that the Company makes from time to time with the SEC. These forward-looking statements speak only as of the date hereof, and the Company expressly disclaims any obligation to update or revise any forward-looking statement, except as otherwise required by law, whether as a result of new information, future events or otherwise.

Item 9.01 Financial Statements and Exhibits.